kynurenine has been researched along with Chronic Disease in 37 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Excerpt | Relevance | Reference |
|---|---|---|
| "It was our objective to increase the body of data regarding the value of kynurenine as a biomarker in chronic heart failure (CHF)." | 7.91 | Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease. ( Armbruster, FP; Bankovic, D; Boschann, F; Dschietzig, TB; Kellner, KH; Klüsener, R; Meinitzer, A; Melzer, C; Mitrovic, V; Ruppert, J; Sasse, K, 2019) |
| " Here we show that a superoxide-dependent step in tryptophan metabolism along the kynurenine pathway is blocked in CGD mice with lethal pulmonary aspergillosis, leading to unrestrained Vgamma1(+) gammadelta T-cell reactivity, dominant production of interleukin (IL)-17, defective regulatory T-cell activity and acute inflammatory lung injury." | 7.74 | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. ( Bistoni, F; D'Angelo, C; De Luca, A; Fallarino, F; Fioretti, MC; Grohmann, U; Montagnoli, C; Puccetti, P; Romani, L; Segal, BH; Vacca, C; Zelante, T, 2008) |
| "The results of our clinical observations of 102 patients with chronic glomerulonephritis with normal renal function have shown that hyperkynureninemia in 22." | 7.70 | Kynurenine and neopterin in chronic glomerulonephritis. ( Bratslavska, O; Fuchs, D; Groma, V; Martinsons, A; Rudzite, V; Widner, B, 1999) |
| "Kynurenines are a wide range of catabolites which derive from tryptophan through the "Kynurenine Pathway" (KP)." | 6.53 | The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia. ( Ballesteros, I; Cuartero, MI; de la Parra, J; García-Culebras, A; Lizasoain, I; Moro, MÁ, 2016) |
| "Chronic inflammation is associated with physical frailty and functional decline in older adults; however, the molecular mechanisms of this linkage are not understood." | 5.56 | Kynurenines link chronic inflammation to functional decline and physical frailty. ( Abadir, PM; Chung, T; de Cabo, R; Ferrucci, L; Hoke, A; Joca, H; Khadeer, M; Le, A; Lovett, J; Moaddel, R; Tian, J; Walston, J; Ward, C; Westbrook, R; Xue, QL; Yang, H, 2020) |
| "The kynurenine blood level was found to correlate with seizures." | 5.27 | [Elevated kynurenine concentration in the blood serum of children with epilepsy and bronchial asthma]. ( Buzdin, VV; Ivanova, NA; Nikitina, ZS; Ryzhov, IV, 1988) |
| "It was our objective to increase the body of data regarding the value of kynurenine as a biomarker in chronic heart failure (CHF)." | 3.91 | Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease. ( Armbruster, FP; Bankovic, D; Boschann, F; Dschietzig, TB; Kellner, KH; Klüsener, R; Meinitzer, A; Melzer, C; Mitrovic, V; Ruppert, J; Sasse, K, 2019) |
| "We demonstrated that confronting mice to the Unpredictable Chronic Mild Stress (UCMS) procedure-a validated model of stress-induced depression-results in behavioural alterations and biochemical changes in the kynurenine pathway (KP), suspected to modify the glutamatergic neurotransmission through the imbalance between downstream metabolites such as 3-hydroxykynurenine, quinolinic and kynurenic acids." | 3.83 | Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine. ( Barone, PR; Belzung, C; Callebert, J; Guillemin, GJ; Laugeray, A; Launay, JM; Mutlu, O, 2016) |
| " Here we show that a superoxide-dependent step in tryptophan metabolism along the kynurenine pathway is blocked in CGD mice with lethal pulmonary aspergillosis, leading to unrestrained Vgamma1(+) gammadelta T-cell reactivity, dominant production of interleukin (IL)-17, defective regulatory T-cell activity and acute inflammatory lung injury." | 3.74 | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. ( Bistoni, F; D'Angelo, C; De Luca, A; Fallarino, F; Fioretti, MC; Grohmann, U; Montagnoli, C; Puccetti, P; Romani, L; Segal, BH; Vacca, C; Zelante, T, 2008) |
| "The results of our clinical observations of 102 patients with chronic glomerulonephritis with normal renal function have shown that hyperkynureninemia in 22." | 3.70 | Kynurenine and neopterin in chronic glomerulonephritis. ( Bratslavska, O; Fuchs, D; Groma, V; Martinsons, A; Rudzite, V; Widner, B, 1999) |
| "Kynurenines are a wide range of catabolites which derive from tryptophan through the "Kynurenine Pathway" (KP)." | 2.53 | The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia. ( Ballesteros, I; Cuartero, MI; de la Parra, J; García-Culebras, A; Lizasoain, I; Moro, MÁ, 2016) |
| "Chronic inflammation is associated with physical frailty and functional decline in older adults; however, the molecular mechanisms of this linkage are not understood." | 1.56 | Kynurenines link chronic inflammation to functional decline and physical frailty. ( Abadir, PM; Chung, T; de Cabo, R; Ferrucci, L; Hoke, A; Joca, H; Khadeer, M; Le, A; Lovett, J; Moaddel, R; Tian, J; Walston, J; Ward, C; Westbrook, R; Xue, QL; Yang, H, 2020) |
| " This stimulation induces indoleamine 2,3-dioxygenase (IDO), an enzyme that reduces the tryptophan bioavailability to synthesize serotonin." | 1.51 | Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats. ( Caso, JR; García-Bueno, B; Leza, JC; Madrigal, JLM; Martín-Hernández, D; Tendilla-Beltrán, H, 2019) |
| "Geriatric depression is a costly health issue, but little is known about its physiological underpinnings." | 1.39 | Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin. ( Dantzer, R; Kelley, KW; Lawson, MA; McCusker, RH; O'Connor, JC; Rodriguez-Zas, SL, 2013) |
| "The kynurenine blood level was found to correlate with seizures." | 1.27 | [Elevated kynurenine concentration in the blood serum of children with epilepsy and bronchial asthma]. ( Buzdin, VV; Ivanova, NA; Nikitina, ZS; Ryzhov, IV, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (24.32) | 18.7374 |
| 1990's | 4 (10.81) | 18.2507 |
| 2000's | 5 (13.51) | 29.6817 |
| 2010's | 17 (45.95) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Westbrook, R | 1 |
| Chung, T | 1 |
| Lovett, J | 1 |
| Ward, C | 1 |
| Joca, H | 1 |
| Yang, H | 1 |
| Khadeer, M | 1 |
| Tian, J | 1 |
| Xue, QL | 1 |
| Le, A | 1 |
| Ferrucci, L | 1 |
| Moaddel, R | 1 |
| de Cabo, R | 1 |
| Hoke, A | 1 |
| Walston, J | 1 |
| Abadir, PM | 1 |
| Joisten, N | 1 |
| Ruas, JL | 1 |
| Braidy, N | 1 |
| Guillemin, GJ | 2 |
| Zimmer, P | 1 |
| Gelpi, M | 1 |
| Hartling, HJ | 1 |
| Ueland, PM | 1 |
| Ullum, H | 1 |
| Trøseid, M | 1 |
| Nielsen, SD | 1 |
| Nagy, BM | 1 |
| Nagaraj, C | 1 |
| Meinitzer, A | 2 |
| Sharma, N | 1 |
| Papp, R | 1 |
| Foris, V | 1 |
| Ghanim, B | 1 |
| Kwapiszewska, G | 1 |
| Kovacs, G | 1 |
| Klepetko, W | 1 |
| Pieber, TR | 1 |
| Mangge, H | 1 |
| Olschewski, H | 1 |
| Olschewski, A | 1 |
| Martín-Hernández, D | 1 |
| Tendilla-Beltrán, H | 1 |
| Madrigal, JLM | 1 |
| García-Bueno, B | 1 |
| Leza, JC | 1 |
| Caso, JR | 1 |
| Hüfner, K | 1 |
| Fuchs, D | 3 |
| Blauth, M | 1 |
| Sperner-Unterweger, B | 1 |
| Su, J | 1 |
| Wang, J | 1 |
| Ma, Y | 1 |
| Li, Q | 1 |
| Yang, Y | 1 |
| Huang, L | 1 |
| Wang, H | 1 |
| Li, H | 1 |
| Wang, Z | 1 |
| Tong, J | 1 |
| Huang, D | 1 |
| Bai, X | 1 |
| Yu, M | 1 |
| Bu, L | 1 |
| Fei, J | 1 |
| Huang, F | 1 |
| Dschietzig, TB | 1 |
| Kellner, KH | 1 |
| Sasse, K | 1 |
| Boschann, F | 1 |
| Klüsener, R | 1 |
| Ruppert, J | 1 |
| Armbruster, FP | 1 |
| Bankovic, D | 1 |
| Mitrovic, V | 1 |
| Melzer, C | 1 |
| Kelley, KW | 1 |
| O'Connor, JC | 1 |
| Lawson, MA | 1 |
| Dantzer, R | 1 |
| Rodriguez-Zas, SL | 1 |
| McCusker, RH | 1 |
| Gibney, SM | 1 |
| Fagan, EM | 1 |
| Waldron, AM | 1 |
| O'Byrne, J | 1 |
| Connor, TJ | 1 |
| Harkin, A | 1 |
| Cuartero, MI | 1 |
| de la Parra, J | 1 |
| García-Culebras, A | 1 |
| Ballesteros, I | 1 |
| Lizasoain, I | 1 |
| Moro, MÁ | 1 |
| Schwieler, L | 1 |
| Larsson, MK | 1 |
| Skogh, E | 1 |
| Kegel, ME | 1 |
| Orhan, F | 1 |
| Abdelmoaty, S | 1 |
| Finn, A | 1 |
| Bhat, M | 1 |
| Samuelsson, M | 1 |
| Lundberg, K | 1 |
| Dahl, ML | 1 |
| Sellgren, C | 1 |
| Schuppe-Koistinen, I | 1 |
| Svensson, C | 1 |
| Erhardt, S | 1 |
| Engberg, G | 1 |
| Mahmoud, ME | 1 |
| Ihara, F | 1 |
| Fereig, RM | 1 |
| Nishimura, M | 1 |
| Nishikawa, Y | 1 |
| Laugeray, A | 2 |
| Launay, JM | 2 |
| Callebert, J | 2 |
| Mutlu, O | 1 |
| Belzung, C | 2 |
| Barone, PR | 2 |
| Pawlak, K | 1 |
| Tankiewicz, J | 1 |
| Mysliwiec, M | 1 |
| Pawlak, D | 1 |
| Surget, A | 1 |
| Bercik, P | 1 |
| Verdu, EF | 1 |
| Foster, JA | 1 |
| Macri, J | 1 |
| Potter, M | 1 |
| Huang, X | 1 |
| Malinowski, P | 1 |
| Jackson, W | 1 |
| Blennerhassett, P | 1 |
| Neufeld, KA | 1 |
| Lu, J | 1 |
| Khan, WI | 1 |
| Corthesy-Theulaz, I | 1 |
| Cherbut, C | 1 |
| Bergonzelli, GE | 1 |
| Collins, SM | 1 |
| Zádori, D | 1 |
| Klivényi, P | 1 |
| Plangár, I | 1 |
| Toldi, J | 1 |
| Vécsei, L | 1 |
| Knubel, CP | 1 |
| Martínez, FF | 1 |
| Acosta Rodríguez, EV | 1 |
| Altamirano, A | 1 |
| Rivarola, HW | 1 |
| Diaz Luján, C | 1 |
| Fretes, RE | 1 |
| Cervi, L | 1 |
| Motrán, CC | 1 |
| Kwon, S | 1 |
| Lee, B | 1 |
| Yeom, M | 1 |
| Sur, BJ | 1 |
| Kim, M | 1 |
| Kim, ST | 1 |
| Park, HJ | 1 |
| Lee, H | 1 |
| Hahm, DH | 1 |
| Schroecksnadel, K | 1 |
| Wirleitner, B | 1 |
| Melchior, D | 1 |
| Le Floc'h, N | 1 |
| Sève, B | 1 |
| Mackay, GM | 1 |
| Forrest, CM | 1 |
| Stoy, N | 1 |
| Christofides, J | 1 |
| Egerton, M | 1 |
| Stone, TW | 1 |
| Darlington, LG | 1 |
| Romani, L | 1 |
| Fallarino, F | 1 |
| De Luca, A | 1 |
| Montagnoli, C | 1 |
| D'Angelo, C | 1 |
| Zelante, T | 1 |
| Vacca, C | 1 |
| Bistoni, F | 1 |
| Fioretti, MC | 1 |
| Grohmann, U | 1 |
| Segal, BH | 1 |
| Puccetti, P | 1 |
| Borisenko, KK | 1 |
| Guseĭnova, RS | 2 |
| Meyer, KC | 1 |
| Arend, RA | 1 |
| Kalayoglu, MV | 1 |
| Rosenthal, NS | 1 |
| Byrne, GI | 1 |
| Brown, RR | 1 |
| Issa, F | 1 |
| Gerhardt, GA | 1 |
| Bartko, JJ | 1 |
| Suddath, RL | 1 |
| Lynch, M | 1 |
| Gamache, PH | 1 |
| Freedman, R | 1 |
| Wyatt, RJ | 1 |
| Kirch, DG | 1 |
| Du, F | 1 |
| Williamson, J | 1 |
| Bertram, E | 1 |
| Lothman, E | 1 |
| Okuno, E | 1 |
| Schwarcz, R | 1 |
| Martinsons, A | 1 |
| Rudzite, V | 1 |
| Groma, V | 1 |
| Bratslavska, O | 1 |
| Widner, B | 1 |
| Crow, TJ | 1 |
| Baker, HF | 1 |
| Cross, AJ | 1 |
| Joseph, MH | 1 |
| Lofthouse, R | 1 |
| Longden, A | 1 |
| Owen, F | 1 |
| Riley, GJ | 1 |
| Glover, V | 1 |
| Killpack, WS | 1 |
| Rossouw, JE | 1 |
| Labadarios, D | 1 |
| Davis, M | 1 |
| Williams, R | 1 |
| Ivanova, NA | 1 |
| Ryzhov, IV | 1 |
| Buzdin, VV | 1 |
| Nikitina, ZS | 1 |
| Heeley, AF | 1 |
| Heeley, ME | 1 |
| Hardy, J | 1 |
| Soothill, JF | 1 |
| Kontsevaia, NG | 1 |
| Kondrat'ev, VG | 1 |
| Iaia, E | 1 |
| Di Lernia, C | 1 |
| Sconosciuto, C | 1 |
| Knapp, A | 1 |
| Wolfram, G | 1 |
| Posch, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Longitudinal Study of Inflammatory Pathways in Depression[NCT04159207] | 160 participants (Anticipated) | Observational | 2019-10-01 | Recruiting | |||
| The Safety and Effectiveness of Probiotic Supplementation on Bipolar Depression: a Proof of Concept Randomized Controlled Trial[NCT02155972] | Phase 2 | 16 participants (Actual) | Interventional | 2013-05-31 | Terminated (stopped due to The trial was terminated because of inability to recruit the needed number of participants) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for kynurenine and Chronic Disease
| Article | Year |
|---|---|
The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?
Topics: Chronic Disease; Humans; Kynurenic Acid; Kynurenine; Quinolinic Acid; Tryptophan | 2021 |
The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.
Topics: Acute Disease; Brain Ischemia; Chronic Disease; Humans; Kynurenine; Metabolic Networks and Pathways; | 2016 |
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.
Topics: Animals; Chronic Disease; Cytoprotection; Humans; Kynurenine; Mitochondria; Neurodegenerative Diseas | 2011 |
1 trial available for kynurenine and Chronic Disease
| Article | Year |
|---|---|
A multidimensional approach to analysis of cerebrospinal fluid biogenic amines in schizophrenia: I. Comparisons with healthy control subjects and neuroleptic-treated/unmedicated pairs analyses.
Topics: Adult; Biogenic Amines; Chromatography, High Pressure Liquid; Chronic Disease; Dopamine; Double-Blin | 1994 |
33 other studies available for kynurenine and Chronic Disease
| Article | Year |
|---|---|
Kynurenines link chronic inflammation to functional decline and physical frailty.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine; Chronic Disease; Cytokines; Disease Models, Anima | 2020 |
Tryptophan catabolism and immune activation in primary and chronic HIV infection.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes | 2017 |
Importance of kynurenine in pulmonary hypertension.
Topics: Adolescent; Adult; Aged; Animals; Child; Chronic Disease; Female; Humans; Hypertension, Pulmonary; K | 2017 |
Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
Topics: Animals; Antidepressive Agents; Chronic Disease; Cytokines; Frontal Lobe; Glutamate Plasma Membrane | 2019 |
How acute and chronic physical disease may influence mental health - An Analysis of neurotransmitter precursor amino acid levels.
Topics: Acute Disease; Adult; Aged; Amino Acids; Anxiety Disorders; C-Reactive Protein; Chronic Disease; Dep | 2019 |
Inflammation associated with chronic heart failure leads to enhanced susceptibility to depression.
Topics: Animals; Brain; Chronic Disease; Cytokines; Depression; Heart Failure; Hypothalamo-Hypophyseal Syste | 2019 |
Plasma Kynurenine Predicts Severity and Complications of Heart Failure and Associates with Established Biochemical and Clinical Markers of Disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Female; Heart Failure; Humans; Immunoassay; Ky | 2019 |
Aging leads to prolonged duration of inflammation-induced depression-like behavior caused by Bacillus Calmette-Guérin.
Topics: Aging; Anhedonia; Animals; Behavior, Animal; Body Weight; Chronic Disease; Depression; Hindlimb Susp | 2013 |
Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour.
Topics: Allopurinol; Animals; Antidepressive Agents; Cerebral Cortex; Chronic Disease; Corticosterone; Depre | 2014 |
Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia--significance for activation of the kynurenine pathway.
Topics: Adult; Astrocytes; Cells, Cultured; Cerebral Cortex; Chronic Disease; Female; Humans; Interleukin-6; | 2015 |
Induction of depression-related behaviors by reactivation of chronic Toxoplasma gondii infection in mice.
Topics: Animals; Brain; Chronic Disease; Depressive Disorder; Dietary Sucrose; Disease Models, Animal; Dopam | 2016 |
Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Chronic Disease; Cytokines; Depression; Fluoxetin | 2016 |
Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Female; Humans; Kidney Diseases; Kynurenine; Lip | 2009 |
Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.
Topics: Animals; Brain; Chronic Disease; Depressive Disorder, Major; Disease Models, Animal; Hydroxyindoleac | 2010 |
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice.
Topics: Animals; Anxiety; Behavior, Animal; Brain-Derived Neurotrophic Factor; Chronic Disease; Colitis; Cyt | 2010 |
3-Hydroxy kynurenine treatment controls T. cruzi replication and the inflammatory pathology preventing the clinical symptoms of chronic Chagas disease.
Topics: Animals; Chagas Disease; Chronic Disease; Female; Inflammation; Interferon-gamma; Kynurenine; Mice; | 2011 |
Modulatory effects of acupuncture on murine depression-like behavior following chronic systemic inflammation.
Topics: Acupuncture Therapy; Animals; Behavior, Animal; Brain; Chromatography, High Pressure Liquid; Chronic | 2012 |
Anemia and congestive heart failure.
Topics: Anemia; Causality; Cell Division; Chronic Disease; Comorbidity; Dioxygenases; Heart Failure; Hematop | 2003 |
Effects of chronic lung inflammation on tryptophan metabolism in piglets.
Topics: Animals; Chronic Disease; Freund's Adjuvant; Kynurenine; Pneumonia; Sus scrofa; Swine Diseases; Tryp | 2003 |
Tryptophan metabolism and oxidative stress in patients with chronic brain injury.
Topics: Adult; Aged; Brain Injuries; Chromatography, High Pressure Liquid; Chronic Disease; Enzyme-Linked Im | 2006 |
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Chronic Disease; Disease Models, Animal; Granulomatou | 2008 |
[Tryptophan metabolism in psoriasis].
Topics: Adult; Chronic Disease; Circadian Rhythm; Female; Humans; Kynurenine; Male; Middle Aged; Psoriasis; | 1981 |
Tryptophan metabolism in chronic inflammatory lung disease.
Topics: Actins; Adult; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Chronic Disease; | 1995 |
Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells.
Topics: 3-Hydroxyanthranilate 3,4-Dioxygenase; Animals; Astrocytes; Cell Death; Cerebral Cortex; Chronic Dis | 1993 |
Kynurenine and neopterin in chronic glomerulonephritis.
Topics: Biomarkers; Chronic Disease; Creatinine; Fasting; Glomerular Filtration Rate; Glomerulonephritis; Gl | 1999 |
Monoamine mechanisms in chronic schizophrenia: post-mortem neurochemical findings.
Topics: Aged; Brain Chemistry; Catechol O-Methyltransferase; Chronic Disease; Dopamine; Dopamine beta-Hydrox | 1979 |
[Tryptophan metabolic indices in allergic dermatoses].
Topics: Chronic Disease; Dermatitis, Atopic; Female; Humans; Kynurenic Acid; Kynurenine; Male; Prurigo; Pyri | 1979 |
The degradation of tryptophan in severe liver disease.
Topics: Acute Disease; Chronic Disease; Humans; Kynurenine; Liver Diseases; Tryptophan; Vitamins | 1978 |
[Elevated kynurenine concentration in the blood serum of children with epilepsy and bronchial asthma].
Topics: Adolescent; Asthma; Child; Child, Preschool; Chronic Disease; Epilepsy; Female; Humans; Kynurenine; | 1988 |
A disorder of tryptophan metabolism in chronic granulomatous disease.
Topics: Child; Child, Preschool; Chromatography, Paper; Chronic Disease; Granuloma; Humans; Infant, Newborn; | 1970 |
[Balance and metabolism of tryptophan in pneumonia].
Topics: Adult; Chronic Disease; Focal Infection; Humans; Kynurenine; Male; Pneumonia; Spectrophotometry; Try | 1971 |
[Behavior of various enzymes in the serum, kynurenine, lactates, pyruvates, during a course of acute and chronic bronchopneumopathies: relationship to arterial hemogasometry and spirographic data].
Topics: Acute Disease; Adult; Blood Gas Analysis; Chronic Disease; Humans; Kynurenine; Lactates; Pyruvates; | 1971 |
[Chronic urticaria and vitamin B6 dependent disorders in tryptophan metabolism].
Topics: Adolescent; Adult; Aged; Child; Chronic Disease; Female; Humans; Kynurenine; Male; Middle Aged; Pyri | 1970 |